707
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools

&
Pages 205-223 | Received 19 Dec 2007, Accepted 07 Feb 2008, Published online: 20 Oct 2008

References

  • www.unaids.org
  • www.rhodes.edu/biology/glindquester/viruses/pagespass/hiv/hiv.html
  • www.retrovirology.com/content/4/1/50
  • M Carrington, M Dean, MP Martin, and SJ O'Brien. (1990). Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences. Hum Mol Genet 8 (10):1939–1945.
  • M Mack, J Pfirstinger, J Haas, PJ Nelson, P Kufer, G Riethmuller, and D Schlondorff. (2005). Preferential targeting of CD4-CCR5 complexes with bifunctional inhibitors: A novel approach to block HIV-1 infection. Immunology 175:7586–7593.
  • A Berchanski, and A Lapidot. (2007). Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure. Biochim Biophys Acta 1768 (9):2107–2119.
  • S Liu, S Fan, and Z Sun. (2003). Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies. J Mol Model 9 (5):329–336.
  • K Roy, and JT Leonard. (2005). QSAR analyses of 3-(4-Benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists. J Chem Inf Model 45:1352–1368.
  • YD Aher, A Agrawal, PV Bharatam, and P Garg. (2007). 3D-QSAR studies of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists. J Mol Model 13 (4):519–529.
  • Y Xu, H Liu, C Niu, C Luo, X Luo, J Shen, K Chen, and H Jiang. (2004). Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor. Bioorg Med Chem 12 (3):6193–6208.
  • M Song, CM Breneman, and N Sukumar. (2004). Three-dimensional quantitative structure-activity relationship analyses of piperidine-based CCR5 receptor antagonists. Bioorg Med Chem 12 (2):489–499.
  • A Afantitis, G Melagraki, H Sarimveis, PA Koutentis, J Markopoulos, and O Igglessi-Markopoulou. (2006). Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques. J Comput Aided Mol Des 20:83–95.
  • K Roy, and JT Leonard. (2004). QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6- arylsulfonylbenzonitriles and congeners using molecular connectivity and E-state parameters. Bioorg Med Chem 12:745–754.
  • JT Leonard, K. Roy, and QSAR Classical. (2004). modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congener. QSAR Comb Sci 23:23–35.
  • JT Leonard, and K Roy. (2003). QSAR modeling of anti-HIV activities of alkenyldiarylmethanes using topological and physicochemical descriptors. Drug Des Discov 18:165–180.
  • JT Leonard, K. Roy, and QSAR Classical. (2004). modeling of CCR5 receptor binding affinity of substituted benzylpyrazoles. QSAR Comb Sci 23:387–398.
  • K Roy, and JT Leonard. (2005). Classical QSAR modeling of anti-HIV 2,3-diaryl-1,3-thiazolidin-4-ones. QSAR Comb Sci 24:579–592.
  • K Roy, and JT Leonard. (2005). QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation. Bioorg Med Chem 13:2967–2973.
  • K Roy, and JT Leonard. (2006). Topological QSAR modeling of cytotoxicity data of anti-HIV5-phenyl-1-phenylamino-imidazole derivatives using GFA, G/PLS, FA and PCRA techniques. Indian J Chem 45A:126–137.
  • JT Leonard, and K Roy. (2006). QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques. Bioorg Med Chem 14:1039–1046.
  • JT Leonard, and K Roy. (2006). Comparative QSAR modeling of CCR5 receptor binding affinities of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas. Bioorg Med Chem Lett 16:4467–4474.
  • CP Dorn, PE Finke, B Oates, RJ Budhu, SG Mills, M MacCoss, L Malkowitz, MS Springer, BL Daugherty, SL Gould, JA DeMartino, SJ Siciliano, A Carella, G Carver, K Holmes, R Danzeisen, D Hazuda, J Kessler, J Lineberger, M Miller, WA Schleif, and EA Emini. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl) butanes. Bioorg Med Chem Lett 11:259–264.
  • PE Finke, LC Meurer, B Oates, SG Mills, M MacCoss, L Malkowitz, MS Springer, BL Daugherty, SL Gould, JA DeMartino, SJ Sicilino, A Carella, G Carver, K Holmes, R Danzeisen, D Hazuda, J Kessler, J Lineberger, M Miller, WA Schleif, and EA Emini. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl) butanes. Bioorg Med Chem Lett 11:265–270.
  • PE Finke, LC Meurer, B Oates, SK Shah, JL Loebach, SG Mills, M MacCoss, L Castonguay, L Malkowitz, MS Springer, SL Gould, and JL DeMartino. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl) amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl] butanes. Bioorg Med Chem Lett 11:2469–2473.
  • PE Finke, B Oates, SG Mills, M MacCoss, L Malkowitz, MS Springer, SL Gould, JA DeMartino, A Carella, G Carver, K Holmes, R Danzeisen, D Hazuda, J Kessle, J Lineberger, M Miller, WA Schleif, and EA Emini. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: Synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes. Bioorg Med Chem Lett 11:2475–2479.
  • Cerius2 Version 4.10 is a product of Accelrys Inc., San Diego, CA.
  • K Roy, and AS Mandal. (2007). Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones. J Enz Inhib Med Chem DOI: 10.1080/14756360701811379
  • L Eriksson, J Jaworska, AP Worth, MTD Cronin, RM McDowell, and P Gramatica. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification and regression-based QSARs. Environ Health Perspect 111:1361–1375.
  • R Guha, and PC Jurs. (2005). Determining the validity of a QSAR model - A classification approach. J Chem Inf Model 45:65–73.
  • JT Leonard, and K Roy. (2006). On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25(3):235–251.
  • K Roy. (2007). On some aspects of validations of predictive QSAR models. Expert Opin Drug Discov 2:1567–1577.
  • B Everitt, S Landau, and M Leese. Cluster analysis. London: Arnold; (2001).
  • ER Dougherty, J Barrera, M Brun, S Kim, RM Cesar, Y Chen, M Bittner, and JM Trent. (2002). Inference from clustering with application to gene-expression microarrays. J Comput Biol 9:105–126.
  • RB Darlington. Regression and linear models. New York: McGraw-Hill; (1990).
  • S Wold. PLS for multivariate linear modeling. In: H van de Waterbeemd, editor. Chemometric methods in molecular design. Weinheim: VCH; (1995). p 195–218.
  • R Franke. Theoretical drug design methods. Amsterdam: Elsevier; (1984).
  • R Franke, and A Gruska. Principal component and factor analysis. In: H van de Waterbeemd, editor. Chemometric methods in molecular design. Weinheim: VCH; (1995). p 113–163.
  • AJ Hopfinger, and JS Tokarsi. Three dimensional quantitative structure-activity relationship analysis. In: PS Charifson, editor. Practical applications of computer-aided drug design. New York: Marcel Dekker; (1997). p 105–164.
  • D Rogers, and AJ Hopfinger. (1994). Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J Chem Inf Comput Sci 34:854–866.
  • J Zupan, and J Gasteiger. Neural networks in chemistry and drug design. Weinheim: Wiley-VCH; (1999).
  • Y Tang, HL Jiang, KX Chen, and RY Ji. (1996). QSAR study of artemisinin (Qinghaosu) derivatives using neural network method. Indian J Chem 35B:325–332.
  • GW Snedecor, and WG Cochran. In: H van de Waterbeemd, editor. Statistical methods. New Delhi: Oxford and IBH; (1967). p 381.
  • S Wold, and L Eriksson. In: H van de Waterbeemd, editor. Chemometric methods in molecular design. Weinheim: VCH; (1995). p 312.
  • AK Debnath. In: AK Ghose, and VN Viswanadhan, editor. Combinatorial library design and evaluation. New York: Marcel Dekker Inc.; (2001). p 73.
  • MINITAB is a statistical software of Minitab Inc., USA.
  • SPSS is a statistical software of SPSS Inc., USA.
  • STATISTICA is a statistical software of STATSOFT Inc., USA.
  • DJ Livingstone, and DW Salt. (2005). Judging the significance of multiple linear regression models. J Med Chem 48:661–663.
  • http://www.port.ac.uk/research/cmd/research/selectionbiasinmultipleregression
  • A Golbraikh, and A Tropsha. (2002). Beware of q2!. J Mol Graphics Mod 20:269–276.
  • P Roy, and K Roy. (2008). On some aspects of variable selection for partial least squares regression models. QSAR Comb Sci 27: 302–313

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.